Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab and Bortezomib in Acquired Hemophilia A
NCT03700229Phase 2Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Oct 2018
- Primary completion
- Oct 2019
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in acquired hemophilia A (AHA), sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
bortezomib
03
Conditions
acquired hemophilia A (AHA)
Beyond the preview
Go deeper on NCT03700229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03700229.